iBraiN Lab (Université de Tours & Inserm) is a multidisciplinary lab, integrating research in Psychiatry, studies in cellular/molecular neuroscience and investigations aimed at developing new technologies for diagnosis and treatment of psychiatric disorders (focusing on methodologies relying on radiopharmaceuticals and ultrasound). It gathers experts in acoustics, chemistry, genetics, philosophy, psychiatry, linguistics, medical imaging, mathematics, neuroscience, philosophy, physics and radiochemistry. Its main objective is to develop personalized therapies for psychiatric disorders, in particular autism and treatment-resistant depression, based on specific biomarkers predicting the efficacy of a given treatment.
The specific objectives of the unit are:
- to improve the comprehension of psychiatric and neurologic disorders by refining diagnosis and treatment
- to develop new imaging technologies and methodologies for the exploration of brain pathologies
- to develop innovative therapies for the treatment of cerebral pathologies
Full text658 |
Notices534 |
Open access63 % |
Keywords
Last deposits
-
Serge Dos Santos, Martin Lints, Nathalie Poirot, Zuzana Farova, Andrus Salupere, et al.. Nonlinear Time Reversal for Non Destructive Testing of complex medium : a review based on multi-physics experiments and signal processing strategies. VIIIth International Workshop NDT in Progress NDTP2015, 2015, Prague (CZ), Czech Republic. ⟨hal-04614125⟩
-
-
Solveig Chilla, Cornelia Hamann, Philippe Prévost, Lina Abed Ibrahim, Sandrine Ferré, et al.. The influence of different first languages on LITMUS nonword-repetition and sentence repetition in second language French and second language German. LITMUS in Action: Comparative Studies across Europe, 29, John Benjamins Publishing Company; John Benjamins Publishing Company, pp.228-262, 2021, Trends in Language Acquisition Research, 9789027209795. ⟨10.1075/tilar.29.08chi⟩. ⟨hal-03404644⟩
-
-
Chloé Vuillamy, Jean-Philippe Arnault, Mathurin Fumery, Laurent Mortier, Sandrine Monestier, et al.. Clostridium difficile infection and immune checkpoint inhibitor–induced colitis in melanoma: 18 cases and a review of the literature. Melanoma Research, 2023, ⟨10.1097/CMR.0000000000000878⟩. ⟨hal-04061838⟩